HistoSonics Stock
HealthTechLooking to sell HistoSonics stock or options?
HistoSonics is the creator of an innovative, non-intrusive sonic beam therapy platform designed to annihilate targeted tissues at a sub-cellular level by liquefying them. The company's platform provides custom, tissue-specific treatments with unmatched accuracy and control, devoid of the unwanted side effects commonly associated with current surgical and interventional methods. This allows physicians to consistently monitor the treatment and its impact in real time.
Grand Rapids Business Journal, Gary Comer, HealthQuest Capital, Alpha Wave Global, Varian Medical Systems, Johnson & Johnson Innovation - JJDC, Frederic Moll, Amzak Health, Venture Investors, Fletcher Spaght Ventures, Hatteras Venture Partners, Trout Creek Ventures, State of Wisconsin Investment Board, Early Stage Partners, Lumira Ventures, Grand Angels, Yonjin Venture, Innovation Partnerships, TGap Ventures, Samuel Zell & Robert H Lurie, MINTS (Michigan Investment in New Technology Startups), Daniel Weide, Michigan Capital Network Ventures, Northern Michigan Angels.